More Evidence and More Questions About Paclitaxel-Coated Balloons in the Femoropopliteal Segment

Konstantinos Katsanos. JACC Cardiovasc Interv. 2018.

Free article

. 2018 May 28;11(10):942-944.

doi: 10.1016/j.jcin.2018.02.039. Epub 2018 May 2.

¹ School of Medicine, Patras University Hospital, Patras, Greece. Electronic address: katsanos@med.upatras.gr.

No abstract available

Keywords: balloon; critical limb ischemia; femoropopliteal; paclitaxel; restenosis; target lesion revascularization.

Comment on

12-Month Results From the First-in-Human Randomized Study of the Ranger Paclitaxel-Coated Balloon for Femoropopliteal Treatment.
Steiner S, Willfort-Ehringer A, Sievert H, Geist V, Lichtenberg M, Del Giudice C, Sauguet A, Diaz-Cartelle J, Marx C, Ströbel A, Schult I, Scheinert D; RANGER SFA Investigators. Steiner S, et al. JACC Cardiovasc Interv. 2018 May 28;11(10):934-941. doi: 10.1016/j.jcin.2018.01.276. Epub 2018 May 2. JACC Cardiovasc Interv. 2018. PMID: 29730375 Clinical Trial.